INTRODUCTION – Drug utilization studies assess appropriateness of pharmacotherapy. Rheumatoid arthritis (RA) is an autoimmune disease, which, if untreated, may result in degradation of joints.

OBJECTIVE – To evaluate the prescribed drugs according to WHO drug use indicators.

METHODS – Data collected included Demographics, details of medications prescribed for RA and other co–morbidities.

RESULTS – Average no of drugs per prescription were 4.98 ± 1.21. Methotrexate was prescribed to every patient. Percentage of patients prescribed Single DMARD, Two DMARDS and Three DMARDS were 10%, 48% and 42% respectively. 99.38% and 90.68% of the Drugs for RA were prescribed from NLEM 2015 and 20th WHO Model List of Essential Medicines (March 2017) respectively.75.9% drugs were prescribed by Generic name.

CONCLUSION – The standard treatment guidelines for treatment of RA are followed. Drugs were mostly prescribed from the Essential drug lists. Majority of the drugs have been prescribed by generic names.